From: Iodine-125 seed brachytherapy for early stage prostate cancer: a single-institution review
PSA | Evaluable pts. | Pts. with PSA failure | Pts. with a follow-up more than 60 months |
---|---|---|---|
No. of pts. (%) | 141 | 6 (4.3%) | 55 (39.0%) |
Pretreatment PSA | 7.1 ± 2.5 | 6.3 ± 1.5 | 7.0 ± 2.5 |
PSA Nadir | 0.4 ± 0.6 | 1.3 ± 1.6 | 0.1 ± 0.2 |